RMND1
Basic information
Region (hg38): 6:151398898-151452158
Previous symbols: [ "C6orf96" ]
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation defect type 11 (Strong), mode of inheritance: AR
- combined oxidative phosphorylation defect type 11 (Supportive), mode of inheritance: AR
- combined oxidative phosphorylation defect type 11 (Moderate), mode of inheritance: AR
- combined oxidative phosphorylation defect type 11 (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 11 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Renal | 18835491; 23022098; 23022099; 25058219 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (11 variants)
- Combined oxidative phosphorylation defect type 11 (4 variants)
- Mitochondrial disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RMND1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 35 | ||||
missense | 60 | 71 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 11 | 16 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 8 | 7 | 15 | |||
non coding | 53 | 40 | 95 | |||
Total | 13 | 10 | 66 | 87 | 49 |
Highest pathogenic variant AF is 0.0000197
Variants in RMND1
This is a list of pathogenic ClinVar variants found in the RMND1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-151404858-C-CATTT | Benign (Jan 27, 2020) | |||
6-151405040-G-T | Benign (Jun 23, 2018) | |||
6-151405165-G-C | Benign (Jun 23, 2018) | |||
6-151405236-C-G | Combined oxidative phosphorylation defect type 11 • Mitochondrial disease • Inborn genetic diseases | Conflicting classifications of pathogenicity (Mar 17, 2024) | ||
6-151405236-C-T | not specified | Benign (Jan 26, 2024) | ||
6-151405237-A-G | Inborn genetic diseases | Likely pathogenic (Oct 26, 2017) | ||
6-151405246-C-T | Likely benign (Nov 20, 2023) | |||
6-151405248-C-T | Inborn genetic diseases | Uncertain significance (Sep 26, 2023) | ||
6-151405250-T-C | not specified | Likely benign (Aug 02, 2017) | ||
6-151405262-C-T | Uncertain significance (May 25, 2022) | |||
6-151405264-T-G | Benign/Likely benign (Jun 12, 2023) | |||
6-151405278-A-G | Combined oxidative phosphorylation defect type 11 | Uncertain significance (Aug 19, 2022) | ||
6-151405279-AAGTG-A | Likely benign (Sep 08, 2023) | |||
6-151405621-T-C | Benign (Jun 23, 2018) | |||
6-151405624-G-C | Likely benign (Jul 15, 2018) | |||
6-151405662-GC-G | Likely benign (Jul 07, 2018) | |||
6-151405694-C-T | Benign (Jun 23, 2018) | |||
6-151405697-AGTAC-A | Likely benign (Oct 13, 2023) | |||
6-151405699-TAC-T | Likely benign (Oct 24, 2023) | |||
6-151405706-C-G | Likely benign (Oct 28, 2022) | |||
6-151405708-T-C | Likely benign (Jul 17, 2022) | |||
6-151405714-T-C | Uncertain significance (Jul 30, 2022) | |||
6-151405717-T-G | Inborn genetic diseases | Uncertain significance (Aug 30, 2021) | ||
6-151405719-C-A | Mitochondrial disease | Pathogenic (Dec 22, 2015) | ||
6-151405734-G-A | Mitochondrial disease | Pathogenic (Dec 22, 2015) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RMND1 | protein_coding | protein_coding | ENST00000367303 | 11 | 47271 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.09e-9 | 0.526 | 125686 | 0 | 55 | 125741 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.765 | 201 | 234 | 0.859 | 0.0000116 | 2967 |
Missense in Polyphen | 54 | 81.812 | 0.66005 | 1073 | ||
Synonymous | -0.0400 | 84 | 83.5 | 1.01 | 0.00000441 | 838 |
Loss of Function | 1.17 | 17 | 23.0 | 0.738 | 0.00000115 | 292 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000566 | 0.000565 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000265 | 0.000264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000168 | 0.000163 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Required for mitochondrial translation, possibly by coordinating the assembly or maintenance of the mitochondrial ribosome (PubMed:23022098, PubMed:25604853). {ECO:0000269|PubMed:23022098, ECO:0000269|PubMed:25604853}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 11 (COXPD11) [MIM:614922]: A severe, multisystemic, autosomal recessive, disorder characterized by deficiencies of multiple mitochondrial respiratory enzymes leading to neonatal hypotonia and lactic acidosis. Affected individuals may have respiratory insufficiency, foot deformities, or seizures. {ECO:0000269|PubMed:23022098, ECO:0000269|PubMed:23022099, ECO:0000269|PubMed:25604853, ECO:0000269|PubMed:26238252}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.873
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.61
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.807
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rmnd1
- Phenotype
Gene ontology
- Biological process
- translation;positive regulation of mitochondrial translation
- Cellular component
- mitochondrion
- Molecular function
- protein binding